|
|
Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2011 Financial Results - MarketWatch (press release) |
|
|
MarketWatch (press release)
Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, ...
Keryx Biopharmaceuticals Inc (KERX) Posts Quarterly Earnings Results, Misses
|
|
|
|
|
|
<< Start < Prev 751 752 753 754 755 756 757 758 759 760 Next > End >>
|
|
Page 760 of 2630 |